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INTRODUCTION:  Breast  myoblastoma  or granular  cell  tumor  involving  the breast  parenchyma  has  been
described  in detail  for the  ﬁrst  time  since  Abrikossoff  in  1931.  The  location  of  this  injury  to  the  breast
is  very  rare,  accounting  for between  5%  and  15%  of  all cases  of cancer  of the  granular  cells.  We  present
our  experience  regarding  the  identiﬁcation  of  two  cases  because  of  the  relative  rarity  of  this  tumor.  It  is
often confused  with  breast  cancer  on  clinical  and  radiological,  and its diagnosis  can  then be  difﬁcult  for
physicians,  radiologists  and  pathologists.
PRESENTATION  OF  CASES:  We  report  the  cases  of two  young  women  who  came  to  our  attention  because
of  the  presence  of  mass  shoveled  breast,  mobile  and accompanied  by pain  cycle  independent.  In both
cases,  mammography  and  ultrasound  revealed  the  presence  of  heterogeneous  mass  and  irregular,  but  in
one  of  two  such  mass  located  at the Union  of external  quadrants  of  the  left breast  and  was  in contact
with  his serratus  anterior  and  suspicion  for  malignancy.  In  both  cases  the  ‘histology  combined  with
immunohistochemical  study  proved  to be  a granular  cell  tumor.
CONCLUSION:  Although  a granular  cell  tumor  of  the  breast  is  a rare  tumor  breast,  should  be considered  in
the  differential  diagnosis  of  benign  and  malignant  lesions.  Surgeons  and  pathologists  should  keep  in  mind
when  considering  a  granular  cell  tumor  cells with  abundant  granular  cytoplasm  containing  materials  to
avoid  misdiagnosing  breast  cancer,  which  could  lead  to unnecessary  surgery.
©  2016  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
The myoblastoma is a granular cell tumor (GCT), rare, and
escribed for the ﬁrst time by Weber in 1854. It is been fully
escribed by Abrikossoff in 1926; who suspected a myogenic origin
nd therefore deﬁned a granular cell myoblastoma. However, due
o S-100 protein positivity and the similarity of the tumor cells to
he Schwann cells, researchers have proposed that the tumor orig-
nated from Schwann cells; the exact histogenesis of this tumor is
till unknown [1–4]. Born in general in the language but can occur
t any place and at any age, and may  be multifocal. Abrikossoff
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was in 1931 to describe the ﬁrst case of involvement of the breast
parenchyma [2]. Localization of this injury to the breast is very
rare, accounting for between 5% and 15% of all cases GCT [1,2].
Although GCT is well-established entity, is often confused with
clinical examination and radiological breast cancer. Its diagnosis
is a challenge for physicians, radiologists and pathologists [1,5].
We report two  cases of a GCT mimicking breast cancer on mam-
mography and ultrasound. The diagnosis was  made by histological
examination. Through this observation, we  discuss aspects of radio-
clinical, histopathological and treatment of this rare tumor, as well
as the results.
1.1. Presentation ﬁrst case
We report the case of a 36-year-old woman came to our atten-
tion with a palpable mass in her left breast appearance from about
18. She had a personal or family history of cancer. A physical exam-
ination showed a mass of 17 mm,  painless, located to the union
of the outer quadrants of the left breast, without skin changes or
axillary node involvement. Mammography revealed a dense mass
with ill-deﬁned edges. The ultrasound showed a hypoechoic, het-
erogeneous, irregular and poorly limited mass 17 mm, located at
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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he Union of external quadrants of the left breast, to the serra-
us muscle. The mass was suspicious of malignancy (Fig. 1). Gross
xamination, the tumor was 19 mm  at its largest diameter, whitish
n color and had boundaries are not well deﬁned. Microscopic
xamination revealed a benign tumor composed of compact nests
f polygonal cells with well-deﬁned edges phones that contained
ranular eosinophilic cytoplasm, and small, uniform, round nuclei
ithout nuclear pleomorphism or mitotic activity (Figs. 2 and 3).
he immuno-histochemical analysis showed positivity for S-100
rotein (Fig. 4). The cells were negative for cytokeratin and cluster
f differentiation (CD) 163. Based on these data, it was  conﬁrmed
he diagnosis of GCT.
.2. Presentation second case
The second case was that of a young woman of 30 years, came
o our attention because of the presence of right breast lump,
ppeared to be about 12 months and accompanied by not cycli-
al pain. Mammography and ultrasound revealed a mass within
eﬁnite suspicion of ﬁbroadenoma. The patient had no previous
perations and no pregnancies, and there was no family history of
reast cancer. FNAC of nodule did not allow a correct and deﬁnitive
iagnosis, and the patient has undergone surgery lumpectomy. The
peration and the postoperative period were quiet. To date, there
s no recurrence of the lesion. Gross examination the material was
omposed of nodule 27 mm centimeters in diameter and the sur-
ounding breast tissue. Macroscopically fragment appeared as solid
umor gray–white and other fragments were recognized as breast
issue. Microscopically observed a benign tumor. The tumor was
omposed of compact nests and sheets of cells with the edges of
he cells that contain well-deﬁned cytoplasmic eosinophils gran-
les. The cells were fused polygonal in shape. The nuclei are round
r slightly oval, and some of them contain prominent nucleoli (Figs.
 and 2). In different focuses mostly on the periphery of the lesion
ymphoplasmocytic prominent inﬁltration is observed. Rarely in
he suburbs, nerve bundles were seen. Mainly, the tumor was well
eﬁned, however, focuses inﬁltrative growth existed (Figs. 3 and
). Normal breast tissue around the lesion persisted (Fig. 5).
. Discussion
A GCT is a rare tumor that may  arise throughout the body. The
ite anatomical organ of origin is the most common language, fol-
owed by soft tissue [1,4,6]. GCT breast represents between 5% and
5% of all cases GCT [2]. It occurs in a wide range of ages, from
eenagers to the elderly, but most commonly occurs in women
etween 30 and 50 years of age. However, some cases of GCT of
he breast have been described in humans [1,4,6]. Usually presents
s painless mass, well-circumscribed, and generally furniture. Sev-
ral cases have been reported with poorly circumscribed masses
hat may  be attached to the pectoral muscle, mimicking malignancy
1,2]. Involvement of the skin, including the thickening, tethering,
imples and retraction, has been described [2]. The tumor is soli-
ary, but multiple lesions (multifocal) were reported from 5% to
8% of cases [4,6]. In one of our patients, the tumor was  poorly lim-
ted and was in contact with the muscles of the chest wall. GCT
reast stem from intra-lobular breast stroma. They show no pref-
rence side [2,6,7]. Occur more frequently in the upper quadrants
f the breast, in accordance with breast cancer, which generally
s located in the upper outer quadrant. However, a case analysis
roused a great variety of positions, including the upper outer quad-
ant, the upper inner quadrant, the tail axillary, the median line, the
ipple and the retroareolar region [1,2]. The histogenesis of GCT
emains controversial and its unknown etiology. When Abrikossoff
rst described the type of tumor is assumed to originate in skeletalPEN  ACCESS
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muscle [2]. Chung and Work have suggested an origin smooth mus-
cle [8]. Then it was  thought that their origin was from ﬁbroblasts
or undifferentiated mesenchymal cells or histiocytes and Ulrich
et al. showing proof of histiocytic [9]. Furthermore, immunohis-
tochemical proﬁling suggests that it is unlikely to be of muscle
(due to the negativity for alpha-smooth muscle actin) or epithe-
lial (because of the negativity for keratin or epithelial membrane
antigen) origin [10]. Subsequently, other studies have established
that these tumors originate from Schwann cells due to their S-100
protein positivity and the similarity of the tumor cells of Schwann
cells [3]. The presentation of GCT on imaging diagnostic breast is
variable. In mammography, has often been described as a small
(<3 cm)  lesion, ranging from a round, well-circumscribed mass, an
indistinct or spiculated lesion missing calciﬁcations, difﬁcult to dis-
tinguish from carcinoma [4–6]. On ultrasound, can present as a
solid, little injury marginata, with strong shadow back, suggestive
of cancer, or as a more benign appearance of well-circumscribed
mass [1,4,6]. A gross section usually shows a ﬁrm or hard, smooth,
gray–white to yellow tumor, measuring generally three centime-
ters or less, but were reported tumors measuring up to 6 cm.  The
majority of these tumors appears to be well-circumscribed, but in
other cases the margins are poorly deﬁned and can inﬁltrate, as in
one of our cases, the surrounding tissues, in particular ﬁbrous tis-
sue, adipose tissue and the muscle serratus. These features mimic
malignant growth patterns and give the impression of inﬁltrating
carcinoma variant scirrosa [1,2,6,7] Clinical examination and X-ray,
it is impossible to establish a deﬁnitive diagnosis of GCT free breast
biopsy. Sonographically guided percutaneous biopsy of the lesion
is well established as the diagnostic procedure of choice for sam-
pling histopathology [7]. Under the microscope, the tumor is well
circumscribed, but may  have inﬁltrative margins, as indicated in
our case. The cells are arranged in nests and sheets. Are generally
uniform, big, bland and polygonal. However, rarely can be round or
spindle-like form [1,2]. Have distinct edges and abundant granular
eosinophilic cytoplasm, from which this tumor derives its name.
The variation is caused by granular cytoplasmic accumulation of
lysosomes. Nuclei are small, centrally located and hyperchromatic
with one or two nucleoli. They are not displayed mitosis, pleomor-
phism, multiplicity or nuclear atypia [1,2,4,7]. Multi nucleation and
rare mitotic features can be seen, but these features should not be
interpreted as evidence of malignancy. Variable amounts of stroma
collagen are present. Histochemical analysis conﬁrms if the gran-
ules are diastase resistant and periodic acid Schiff positive [1,6]. The
deﬁnitive diagnosis of GCT is only possible with the examination
immunohistochemistry and therefore it is always necessary to tis-
sue samples for a correct diagnosis. The tumor cells are strongly
immunoreactive for S-100 protein. They do not show staining
for cytokeratins, epithelial membrane antigen or mucin. The cells
were reported positive for CD68, carcinoembryonic antigen and
vimentin in some cases in the literature [1,3]. In our cases, the
description of the pathological features was supported by immuno-
histochemistry: S-100 protein-positive and negative cytokeratin.
While most of the TCG behave in a benign, malignant occasional
cases have been described (less than 1% of all GCT, including breast
lesions, are malignant) [4,6,7]. The distinction between benign
and malignant GCT was proposed by Le et al. [11] and Adeniran
et al. [7], and including the criteria of necrosis, spindling, vesicu-
lar nuclei with large nucleoli, increased mitotic activity (more than
two mitoses per 10 high power ﬁeld at ×200 magniﬁcation), high
nuclear cytoplasmic ratio, and nuclear pleomorphism. These cri-
teria classify GCT by histology in atypical (when two of these six
criteria are present) and malignant (when three or more of these
six criteria are met) [4]. GCTs should be distinguished from breast
cancer, particularly scirrhous carcinoma and apocrine. The differ-
ence between GCT and granulomatous inﬂammatory reaction or
a histiocytic tumor is negative for antigens histiocytes-associated,
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lthough reactivity to CD68 has been described in a GCT [12]. GCT
hould be distinguished from metastatic breast cancer who  have
haracteristics of cells oncocytic or clear, as renal cell carcinoma,
alignant melanoma and sarcoma, alveolar soft part [1,6]. Wide
ocal excision with clear margins is the treatment of choice [13,14].
ubtotal excision may  lead to local recurrence. Direct invasion of
n axillary lymph node from a GCT breast that arose in the axillary
ail was reported [1,3,6].
. Conclusion
The reported cases show that although GCT of the breast is a rel-
tively rare breast neoplasm, should always be considered in the
ifferential diagnosis of benign and malignant lesions. The surgeon
hould always be aware that a cytological diagnosis is not always
orrect, and that, in the case of resection, this should be as large as
ossible in order to avoid local recurrences. The pathologist, how-
ver, should keep in mind when considering GCT cells containing
aterials with abundant granular cytoplasm to avoid misdiagnos-
ng breast cancer, which could lead to unnecessary surgery.
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